← Oncology Approval Tracker

FDA DECISION ·

Opdivo + Yervoy

nivolumab + ipilimumab · Bristol Myers Squibb

Traditional approvalTraditional conversionHepatocellular carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with unresectable or metastatic hepatocellular carcinoma who previously received sorafenib.

LAMPGEN ANALYSIS

Why it matters

The same supplement that added first-line use fulfilled the confirmatory requirement for the earlier post-sorafenib accelerated indication.

What research teams should watch

Document prior sorafenib exposure and distinguish this conversion from the simultaneous first-line label extension.

PRIMARY RECORDS

Sources